News
TMCI
10.97
-2.66%
-0.30
Treace Announces First Annual National Bunion Day
Treace Medical Concepts, Inc. Announces the first-ever National Bunion Day in the United States. One in four U.S. Adults alone develop the bunion deformity in their lifetime. The day is an opportunity to help more people learn about the identification and treatment of this common bone deformity.
Barchart · 4d ago
Weekly Report: what happened at TMCI last week (0408-0412)?
Weekly Report · 5d ago
Weekly Report: what happened at TMCI last week (0401-0405)?
Weekly Report · 04/08 09:00
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Treace Medical Concepts, Inc. Has a median price-to-sales ratio of 3.9x in the Medical Equipment industry in the U.S. The company has been growing its revenue more than most other companies. But the company's P/S ratio is not matching its industry peers' growth expectations. This could be a warning sign for the company.
Simply Wall St · 04/05 17:52
Weekly Report: what happened at TMCI last week (0325-0329)?
Weekly Report · 04/01 09:01
Weekly Report: what happened at TMCI last week (0318-0322)?
Weekly Report · 03/25 09:00
Weekly Report: what happened at TMCI last week (0311-0315)?
Weekly Report · 03/18 09:01
Weekly Report: what happened at TMCI last week (0304-0308)?
Weekly Report · 03/11 09:00
Weekly Report: what happened at TMCI last week (0226-0301)?
Weekly Report · 03/04 09:01
Truist Financial Sticks to Their Buy Rating for Treace Medical Concepts (TMCI)
TipRanks · 02/28 12:29
Buy Rating on Treace Medical Concepts: Promising Financial Outlook and Strategic Product Innovation Drive Growth
TipRanks · 02/28 12:08
U.S. RESEARCH ROUNDUP-Autozone, Constellation Energy, Sterling Infrastructure
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Autozone, Constellation Energy, Sterling Infrastructure among companies with new targets. Analysts raise their ratings on several companies. Some of the companies include Acadia Pharmaceuticals, Bumble and Flywire.
Reuters · 02/28 07:20
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 02/27 23:35
Treace Medical Concepts Unveils New Investor Presentation
TipRanks · 02/27 21:36
BRIEF-Treace Medical Q4 EPS USD -0.1
Reuters · 02/27 21:05
Press Release: Treace Medical Concepts Reports -2-
Treace Medical Concepts, Inc. Presents non-GAAP financial measures because it believes they are useful in measuring the company's performance. Treace is a medical technology company with the goal of advancing the surgical management of bunion and related deformities. The company's products include the Lapiplasty(R) 3D Bunion Correction System.
Dow Jones · 02/27 21:05
Press Release: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
Treace Medical Concepts reports financial results for the fourth quarter and full year ended December 31, 2023. The company's flagship Lapiplasty(R) and Adductoplasty(r) procedures continue to grow. Treace is a medical technology company driving a shift in the surgical treatment of bunions and related midfoot deformities.
Dow Jones · 02/27 21:05
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
Treace Medical Concepts, Inc. Reports financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance. Treace is a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities. The company's flagship Lapiplasty and Adductoplasty procedures.
Barchart · 02/27 15:05
Weekly Report: what happened at TMCI last week (0219-0223)?
Weekly Report · 02/26 09:01
Treace Medical Concepts Inc <TMCI.OQ> expected to post a loss of 9 cents a share - Earnings Preview
Treace Medical Concepts Inc expected to post a loss of 9 cents a share. The company is expected to report a 21.7% increase in quarterly revenue to $60.55 million from $49.77 million.
Reuters · 02/24 00:01
More
Webull provides a variety of real-time TMCI stock news. You can receive the latest news about Treace Medical Concepts, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TMCI
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.